Insights into effective protocol structuring: optimizing dosing strategies, experimental design, and statistical approaches

The lack of consistency and reproducibility in preclinical research remains a major ongoing challenge, often caused by poorly designed studies, inadequate attention to statistical power, and limited transparency in reporting. This review addresses this important issue by focusing on the theoretical framework that supports sound research design and by providing a comprehensive guide to developing impactful, ethically sound preclinical projects. The review begins by examining the key components of a well-structured research protocol, starting with the thinking and reasoning paradigms that lay the foundation for effective protocol development. We discuss how to formulate targeted research questions and testable hypotheses, highlighting a "funnel approach" to ensure a logical progression from broad concepts to specific aims and objectives. Central to this is creating a clear and convincing rationale, articulating the study’s significance in the current literature, and justifying the need for the research. Using a hypothetical example, the review explores critical aspects of experimental design, including practical advice on selecting appropriate pharmacological doses based on dose-range-finding acute toxicity studies; determining sample sizes for each group and justifying group allocation based on study endpoints; and defining endpoint metrics. Finally, we outline suitable methods for analyzing both parametric and nonparametric data collected across various endpoint categories, presented in a straightforward, easy-to-understand flowchart. The goal of this methodological review is to equip researchers with the knowledge and practical tools to improve the consistency, reproducibility, and ethical standards of their preclinical studies by providing guidance on protocol development, experimental design, and data analysis.